China Pharmaceutical Holdings: Nearly doubles in value on mask production
** Drug developer's U.S.-listed shares CPHI.A nearly
double to 88 cents premarket - top gainer across U.S. exchanges
** Company says its China-based unit launched production
lines for face masks urn:newsml:reuters.com:*:nPn5pqYGba
** The coronavirus has led to a surge in demand for face
masks and personal protective equipment for health care workers
and general public
** Up to Tuesday's close, stock had risen ~90% this year
(Reporting by Manas Mishra in Bengaluru)
((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780,
outside U.S. +91 806749 2709))
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split